WYRGRL
Based on 1 Customer Validation
WYRGRL is a selective, high-affinity collagen type II-binding peptide with a IC50 of 140 nM. Collagen type II is the most abundant and specific structural protein in the extracellular matrix of articular cartilage. WYRGRL can precisely target small-molecule compounds such as Dexamethasone (HY-14648) and nanocarrier-engineered exosomes to cartilage, significantly enhancing their therapeutic effects on osteoarthritis.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.88%
- CAS No.: 1021155-39-4
- 화학식: C40H59N13O8
- 분자량:849.98
-
보관:
Sealed storage, away from moisture and light.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
-
Immunology/Inflammation Compound Library
HY-L007
-
Cytoskeleton Compound Library
HY-L060
-
Peptide Library
HY-L105
-
Coagulation and Anti-coagulation Compound Library
HY-L136
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Peptide Compound Library
HY-L105S
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
Biological Activity
|
Collagen II 140 nM (IC50) |
When incorporated as a component of the Dexamethasone prodrug, WYRGRL reduces the levels of inflammatory markers and slows the loss of glycosaminoglycans in cartilage models[2].
WYRGRL, after conjugation with exosomes, enhances the chondrocyte-targeting ability of the exosome-hydrogel delivery system, increases the uptake of the exosomes by chondrocytes, prolongs the retention time of exosomes in joints, and improves the systemic anti-osteoarthritis efficacy in vitro and in mouse models[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1021155-39-4
-
Appearance Solid
-
분자량 849.98
-
화학식 C40H59N13O8
-
Color White to off-white
-
Sequence
Trp-Tyr-Arg-Gly-Arg-Leu
-
Sequence Shortening
WYRGRL
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Sealed storage, away from moisture and light
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
용액&용해도
DMSO : 50 mg/mL (58.82 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
순도&문서
-
Data Sheet (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Formica FA, et al. Cartilage-targeting dexamethasone prodrugs increase the efficacy of dexamethasone. J Control Release. 2019;295:118-129. [Content Brief]
[2]. Wan J, et al. Injectable photocrosslinking spherical hydrogel-encapsulated targeting peptide-modified engineered exosomes for osteoarthritis therapy. J Nanobiotechnology. 2023;21(1):284. Published 2023 Aug 21. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.1765 mL | 5.8825 mL | 11.7650 mL | 29.4125 mL |
| 5 mM | 0.2353 mL | 1.1765 mL | 2.3530 mL | 5.8825 mL | |
| 10 mM | 0.1176 mL | 0.5882 mL | 1.1765 mL | 2.9412 mL | |
| 15 mM | 0.0784 mL | 0.3922 mL | 0.7843 mL | 1.9608 mL | |
| 20 mM | 0.0588 mL | 0.2941 mL | 0.5882 mL | 1.4706 mL | |
| 25 mM | 0.0471 mL | 0.2353 mL | 0.4706 mL | 1.1765 mL | |
| 30 mM | 0.0392 mL | 0.1961 mL | 0.3922 mL | 0.9804 mL | |
| 40 mM | 0.0294 mL | 0.1471 mL | 0.2941 mL | 0.7353 mL | |
| 50 mM | 0.0235 mL | 0.1176 mL | 0.2353 mL | 0.5882 mL |
WYRGRL Related Classifications
HY-P10739 Related Classifications
Powered by Bioz